EUVIMEDEUVIMED entdecken
Multizentrische Studie

Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study

Dieuwke Luijten iD, Luca Valerio iD, Gudula J A M Boon, Stefano Barco iD, Harm Jan Bogaard, Marion Delcroix iD, Yvonne Ende-Verhaar, Menno V Huisman iD, Luis Jara-Palomares iD, Karl-Friedrich Kreitner, Lucia J M Kroft iD, Albert T A Mairuhu und 11 weitere

European Respiratory Journal · 2024

DOI: 10.1183/13993003.00544-2024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Dieuwke Luijten und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands d.luijten@lumc.nl. Hauptthemen laut MEDLINE: Pulmonary Embolism, Algorithms, Hypertension, Pulmonary, Computed Tomography Angiography. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Janssen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic thromboembolic pulmonary hypertension (CTEPH) is often diagnosed late in acute pulmonary embolism survivors: more efficient testing to expedite diagnosis may considerably improve patient outcomes. The InShape II algorithm safely rules out CTEPH (failure rate 0.29%) while requiring echocardiography in only 19% of patients but may be improved by adding detailed reading of the computed tomography pulmonary angiography diagnosing the index pulmonary embolism.

Methods

We evaluated 12 new algorithms, incorporating the CTEPH prediction score, ECG reading, N‑terminal pro-brain natriuretic peptide levels and dedicated computed tomography pulmonary angiography reading, in the international InShape II cohort (n=341) and part of the German FOCUS cohort (n=171). Evaluation criteria included failure rate, defined as the incidence of confirmed CTEPH in pulmonary embolism patients in whom echocardiography was deemed unnecessary by the algorithm, and the overall net reclassification index compared to the InShape II algorithm.

Results

The algorithm starting with computed tomography pulmonary angiography reading of the index pulmonary embolism for six signs of CTEPH, followed by ECG/N-terminal pro-brain natriuretic peptide level assessment and echocardiography resulted in the most beneficial change compared to InShape II, with a need for echocardiography in 20% (+5%), a failure rate of 0% and a net reclassification index of +3.5%, reflecting improved performance over the InShape II algorithm. In the FOCUS cohort, this approach lowered echocardiography need to 24% (−6%) and missed no CTEPH cases, with a net reclassification index of +6.0%.

Conclusion

Dedicated computed tomography pulmonary angiography reading of the index pulmonary embolism improved the performance of the InShape II algorithm and may improve the selection of pulmonary embolism survivors who require echocardiography to rule out CTEPH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismAlgorithmsHypertension, PulmonaryComputed Tomography AngiographyNatriuretic Peptide, BrainEchocardiographyPeptide FragmentsHumansFemaleMaleMiddle AgedAgedChronic DiseaseElectrocardiographySurvivorsAcute DiseaseProspective StudiesGermany

Substanzen

Natriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands d.luijten@lumc.nl.
  • Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
  • Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

ORCID-Profile: Dieuwke Luijten, Luca Valerio, Stefano Barco, Marion Delcroix, Menno V Huisman, Luis Jara-Palomares, Lucia J M Kroft, Lilian J Meijboom, Esther J Nossent, Piotr Pruszczyk, Anton Vonk Noordegraaf, Stavros V Konstantinides, Frederikus A Klok

Förderung

  • Janssen

Zitieren

APA

Luijten, D., Valerio, L., Boon, G. J. A. M., Barco, S., Bogaard, H. J., Delcroix, M., Ende-Verhaar, Y., Huisman, M. V., Jara-Palomares, L., Kreitner, K. F., Kroft, L. J. M., Mairuhu, A. T. A., Mavromanoli, A. C., Meijboom, L. J., van Mens, T. E., Ninaber, M. K., Nossent, E. J., Pruszczyk, P., Rosenkranz, S., …, & Klok, F. A. (2024). Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study. European Respiratory Journal. https://doi.org/10.1183/13993003.00544-2024

Vancouver

Luijten D, Valerio L, Boon GJAM, Barco S, Bogaard HJ, Delcroix M, et al. Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study. European Respiratory Journal. 2024. doi:10.1183/13993003.00544-2024

BibTeX
@article{Luijten2024,
  author = {Luijten, Dieuwke and Valerio, Luca and Boon, Gudula J A M and Barco, Stefano and Bogaard, Harm Jan and Delcroix, Marion and Ende-Verhaar, Yvonne and Huisman, Menno V and Jara-Palomares, Luis and Kreitner, Karl-Friedrich and Kroft, Lucia J M and Mairuhu, Albert T A and Mavromanoli, Anna C and Meijboom, Lilian J and van Mens, Thijs E and Ninaber, Maarten K and Nossent, Esther J and Pruszczyk, Piotr and Rosenkranz, Stephan and Vliegen, Hubert and Vonk Noordegraaf, Anton and Konstantinides, Stavros V and Klok, Frederikus A},
  title = {Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study},
  journal = {European Respiratory Journal},
  year = {2024},
  doi = {10.1183/13993003.00544-2024}
}
Kostenlos starten →